May 30, 2024 — Elixir Medical, a developer of technologies to treat cardiovascular and peripheral disease, announced during the recent Euro PCR 2024 in Paris that the PINNACLE I Trial evaluating the safety and performance of its LithiX Hertz Contact Intravascular Lithotripsy System (IVL) — for treatmen

May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.

May 29, 2024 — Congenital heart disease (CHD) is one of the most common congenital anomalies worldwide, which brings a heavy health and financial burden to patients. Early CHD screening and treatment can significantly improve children’s prognosis and quality of life.

May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heart failure, according to research presented at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC).1

May 24, 2024 — The American Heart Association has issued a statement warning that false information about COVID vaccination and heart defects attributed to the Association may be spreading. The misinformation is inaccurately and incorrectly connected to a recent scientific paper on cardiovascular-kidney-metabolic (CKM) syndrome.

May 24, 2024 — Lexicon Pharmaceuticals, Inc. announced a new post-hoc analysis of clinical data showing that INPEFA (sotagliflozin), a dual oral inhibitor of SGLT2 and SGLT1, reduced the risk of heart failure-related events across a diverse population of patients, including patients with preserved ejection fraction (

May 24, 2024 — An artificial intelligence (AI) program developed by investigators in the 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now